Results 151 to 160 of about 204,163 (273)

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

A practical approach to febrile cancer patients:  Diagnostic stewardship in Oncology units [version 2; peer review: 2 approved]

F1000Research
Introduction Cancer and cytotoxic chemotherapy used for its treatment predispose to severe and often fatal infections. Prompt diagnosis and timely antibiotic therapy are crucial, with delays in therapy initiation having high mortality.
Prashantha B., Pooja Rao, Sanyo D'souza, Anisha Maria Fernandes, Sridevi H.B., Suchitra Shenoy M   +5 more
doaj   +1 more source

Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non‐Small Cell Lung Cancer: A Single‐Institution Retrospective Study

Thoracic Cancer, Volume 17, Issue 9, May 2026.
Docetaxel plus ramucirumab achieved effective control of malignant pleural effusion but showed modest benefit for cerebral edema in patients with advanced non‐small cell lung cancer. ABSTRACT Background Malignant pleural effusion (MPE) is associated with a poor prognosis and quality of life in patients with non‐small cell lung cancer (NSCLC ...
Meiko Morita, Kazushige Wakuda, Suguru Matsuda, Motoki Sekikawa, Keita Miura, Hiroaki Kodama, Michitoshi Yabe, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi   +14 more
wiley   +1 more source

CACA guidelines for managing cancer therapy-induced neutropenia (2026)

Holistic Integrative Oncology
Anticancer therapy, encompassing systemic therapies such as chemotherapy, targeted therapy, and immunotherapy, as well as radiotherapy, can induce neutropenia.
Li Xiao, Fenghua Wang, Ying Yuan, Shu Xia, Wenxing Qin, Xiaotian Zhang, Yanhong Deng, Xianglin Yuan, Yi Ba, Jun Zhang, China Anti-Cancer Association Committee of Neoplastic Supportive-Care (CONS)   +10 more
doaj   +1 more source

Mean Platelet Volume-to-Albumin Ratio as a Predictor of Mortality in Patients with Febrile Neutropenia: An Observational Study

Medicina
Background and Objectives: Febrile neutropenia (FN) is a life-threatening complication in cancer patients, necessitating early risk stratification for optimal management.
Jelena Dimitrijević, Marina Čalamać, Ognjen Đurmez, Marko Stojanović   +3 more
doaj   +1 more source

Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions

European Journal of Haematology, Volume 116, Issue 5, Page 522-534, May 2026.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) remains the most common aggressive lymphoma, representing a biologically heterogeneous disease with diverse clinical behaviors. For more than two decades, R‐CHOP has been the cornerstone of frontline treatment, curing approximately two‐thirds of patients.
Mamdouh Skafi, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Fortunato Morabito, Enrica Antonia Martino, Massimo Gentile   +12 more
wiley   +1 more source

Impact of Routine Respiratory Pathogen Panel Test on Outcome of Pediatric Oncology Patients With Febrile Neutropenia

Cancer Reports
Background Infection is a significant cause of morbidity and mortality in pediatric oncology patients, especially during neutropenia. While bacterial infections are traditionally considered the primary cause of febrile neutropenia, the growing use of ...
Farrah Gaston, Alexander Tran, Collins Odhiambo, Mustafa Bakir   +3 more
doaj   +1 more source

A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of Secondary Infections in Febrile, Neutropenic Patients with Cancer [PDF]

, 2017
Background. Neutropenic patients with cancer may develop several episodes of fever and infection during chemotherapy-induced myeloaplasia. Methods.
Akova, Murat, Calandra, Thierry, Paesmans, Marianne, Viscoli, Claudio   +3 more
core  

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment [PDF]

, 2017
A Rai, AG Tolcher, AX Zhu, Caio Max S Rocha-Lima, David Portnoy, DP Brooks, E Gabriela Chiorean, E Suzuki, J Albores-Saavedra, J Nelson, J Valle, JE Rogers, JF Guion-Dussere, Jitendra Gandhi, L Goyal, M Yanagisawa, Manik Amin, NV Rajeshkumar, NV Rajeshkumar, P Papakostas, R Pazdur, Richard Kim, RK Jain, RL Siegel, S He, SC Lee, SY Oh, T Sasaki, T Walter, Tao Song, William P Harris   +30 more
core   +3 more sources

The Role of Febrile Neutropenia Guideline's Implementation on Mortality Rate in Dharmais Hospital-National Cancer Center [PDF]

, 2018
Introduction: Febrile neutropenia have a high morbidity and mortality impact for the patient. The mortality rate of febrile neutropenia in 2002 was 38.8%, while it was 27.3% in 2009.
Ranuhardy, D. (Dody)
core